73 related articles for article (PubMed ID: 38584220)
1. An original aneuploidy-related gene model for predicting lung adenocarcinoma survival and guiding therapy.
Zhang Y; Li D
Sci Rep; 2024 Apr; 14(1):8135. PubMed ID: 38584220
[TBL] [Abstract][Full Text] [Related]
2. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.
Shu J; Jiang J; Zhao G
Front Immunol; 2023; 14():1177847. PubMed ID: 37583701
[TBL] [Abstract][Full Text] [Related]
4. Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes.
Li F; Niu Y; Zhao W; Yan C; Qi Y
Sci Rep; 2022 Nov; 12(1):19857. PubMed ID: 36400857
[TBL] [Abstract][Full Text] [Related]
5. Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.
Zeng W; Wang J; Yang J; Chen Z; Cui Y; Li Q; Luo G; Ding H; Ju S; Li B; Chen J; Xie Y; Tong X; Liu M; Zhao J
Front Immunol; 2023; 14():1217590. PubMed ID: 37492563
[TBL] [Abstract][Full Text] [Related]
6. Identification of aneuploidy-related gene signature to predict survival in head and neck squamous cell carcinomas.
Liu Y; Yuan Y; Chen T; Xiao H; Zhang X; Zhang F
Aging (Albany NY); 2023 Nov; 15(22):13100-13117. PubMed ID: 37988195
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatic analysis of underlying mechanisms of Kawasaki disease via Weighted Gene Correlation Network Analysis (WGCNA) and the Least Absolute Shrinkage and Selection Operator method (LASSO) regression model.
Xie Y; Shi H; Han B
BMC Pediatr; 2023 Feb; 23(1):90. PubMed ID: 36829193
[TBL] [Abstract][Full Text] [Related]
8. Tumor aneuploidy predicts survival following immunotherapy across multiple cancers.
Spurr LF; Weichselbaum RR; Pitroda SP
Nat Genet; 2022 Dec; 54(12):1782-1785. PubMed ID: 36443443
[TBL] [Abstract][Full Text] [Related]
9. MARCH1 as a novel immune-related prognostic biomarker that shapes an inflamed tumor microenvironment in lung adenocarcinoma.
Xu Z; Liu J; Liu Z; Zhang H
Front Oncol; 2022; 12():1008753. PubMed ID: 36313698
[TBL] [Abstract][Full Text] [Related]
10. Surgical efficacy and survival prediction of patients with unspecified malignant bone tumors.
He S; Jiang R; Sun H; Yang J; Ye C; Liu W; Yang X; Cai X; Xiao J
BMC Cancer; 2022 Oct; 22(1):1078. PubMed ID: 36266614
[TBL] [Abstract][Full Text] [Related]
11. SEC61G Promotes Cervical Cancer Proliferation by Activating MAPK Signaling Pathway.
Fan Y; Wang Y; Liu F; Wang H; Li Q
Dis Markers; 2022; 2022():7016079. PubMed ID: 36092956
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of Gene Signatures of m6ARNA Methylation Regulators in Lung Adenocarcinoma and Development of a Risk Scoring System.
Gao C; Li H; Ma W; Zhang Q; Liu C; Liu L; Zhuang J; Sun C
J Immunol Res; 2022; 2022():7519838. PubMed ID: 36061307
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
